2026 ICD-10-CM Diagnosis Code G21.11Neuroleptic induced parkinsonism
ICD-10-CM Codes›G00–G99›G20-G26›G21
- Billable — Valid for Submission
- Not Chronic
G21.11 is a billable ICD-10-CM diagnosis code for neuroleptic induced parkinsonism. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). Coders also document this condition as neuroleptic-induced parkinsonism. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Drug induced or toxic related condition and Other nervous system disorders (often hereditary or degenerative).
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Neuroleptic-induced parkinsonism
- Parkinsonism caused by drug
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Use Additional Code
Type 1 Excludes
- malignant neuroleptic syndrome G21.0
The “use additional code” indicates that a secondary code could be used to further specify the patient’s condition. This note is not mandatory and is only used if enough information is available to assign an additional code.
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Parkinsonism (idiopathic) (primary) - G20.C
- due to
- neuroleptic - G21.11
- neuroleptic induced - G21.11
- due to
- neuroleptic - G21.11
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Parkinsonism(idiopathic) (primary)
- due to
- drugs NEC
- neuroleptic
- Parkinsonism(idiopathic) (primary)
- neuroleptic induced
- Parkinsonism(idiopathic) (primary)
- secondary
- due to
- drugs NEC
- neuroleptic
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Patient EducationClinical
Drug Reactions
Most of the time, medicines make our lives better. They reduce aches and pains, fight infections, and control problems such as high blood pressure or diabetes. But medicines can also cause unwanted reactions, such as drug interactions, side effects, and allergies.
The full article covers:
- What is a drug interaction?
- What are side effects?
- What are drug allergies?
- How can I stay safe when taking medicines?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert G21.11 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About G21.11Overview
Is G21.11 (Other drug-induced secondary parkinsonism) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report neuroleptic induced parkinsonism on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What is the ICD-9 equivalent of G21.11?
Under the General Equivalence Mappings, neuroleptic induced parkinsonism converts to ICD-9-CM 332.1 (secondary parkinsonism). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.
